Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Heterozygous deletion at the RLN1 locus in a family with testicular germ cell cancer identified by integrating copy number variation data with phenome and interactome information

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Association between chemical pattern in breast milk and congenital cryptorchidism: modelling of complex human exposures

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Associations between congenital cryptorchidism in newborn boys and levels of dioxins and PCBs in placenta

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Cumulative risk assessment of phthalate exposure of Danish children and adolescents using the hazard index approach

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Early breast development in girls after prenatal exposure to non-persistent pesticides

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Populations, decreasing fertility, and reproductive health

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Medium-throughput Screening Assays for Assessment of Effects on Ca2+-Signaling and Acrosome Reaction in Human Sperm

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Variations in repeated serum concentrations of UV filters, phthalates, phenols and parabens during pregnancy

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. An update on semen quality among young Finnish men and comparison with Danish data

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
To search for disease-related copy number variations (CNVs) in families with a high frequency of germ cell tumours (GCT), we analysed 16 individuals from four families by array comparative genomic hybridization (aCGH) and applied an integrative systems biology algorithm that prioritizes risk-associated genes among loci targeted by CNVs. The top-ranked candidate, RLN1, encoding a Relaxin-H1 peptide, although only detected in one of the families, was selected for further investigations. Validation of the CNV at the RLN1 locus was performed as an association study using qPCR with 106 sporadic testicular GCT patients and 200 healthy controls. Observed CNV frequencies of 1.9% among cases and 1.5% amongst controls were not significantly different and this was further confirmed by CNV data extracted from a genome-wide analysis of 189 cases and 380 controls, where similar frequencies of 2.2% were observed in both groups (p=1). Immunohistochemistry for Relaxin-H1 (RLN1), Relaxin-H2 (RLN2) and their cognate receptor, RXFP1, detected one, and in some cases both, of the relaxins in Leydig cells, Sertoli cells and a subset of neoplastic germ cells, whereas the receptor was present in Leydig cells and spermatids. Collectively, the findings show that a heterozygous loss at the RLN1 locus is not a genetic factor mediating high population-wide risk for testicular germ cell tumour, but do not exclude a contribution of this aberration in some cases of cancer. The preliminary expression data suggest a possible role of the relaxin peptides in spermatogenesis and warrant further studies.
Original languageEnglish
JournalInternational Journal of Andrology
Volume34
Issue number4 Pt 2
Pages (from-to)e122-32
ISSN0105-6263
DOIs
Publication statusPublished - 1 Aug 2011

ID: 32777183